We are live on ! Find out more
QF

QVT Financial Portfolio holdings

AUM $1.37B
1-Year Est. Return 148.1%
This Fund
S&P 500
This Quarter Est. Return
-9.65%
1 Year Est. Return
+148.1%
3 Year Est. Return
+280.64%
5 Year Est. Return
+413.55%
10 Year Est. Return
+2,213.36%
AUM
$1.77B
AUM Growth
-$912M
Cap. Flow
-$611M
Cap. Flow %
-34.49%
Top 10 Hldgs %
80.33%
Holding
75
New
9
Increased
8
Reduced
26
Closed
14

Sector Composition

Rank Sector Weight
1 Healthcare 57.85%
2 Consumer Discretionary 4.04%
3 Communication Services 3.86%
4 Financials 2.91%
5 Energy 1.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MYOV
1
DELISTED
Myovant Sciences Ltd.
MYOV
$471M 26.56%
37,231,342
SIOX
2
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
$395M 22.3%
9,375,000
XBI icon
3
PUT
State Street SPDR S&P Biotech ETF
XBI
$10.1B
$127M 7.16%
1,495,000
-2,255,000
-60% -$189M
ABUS icon
4
Arbutus Biopharma
ABUS
$865M
$80.9M 4.56%
16,013,540
MMYT icon
5
MakeMyTrip
MMYT
$4.67B
$40.9M 2.31%
1,416,841
-649,160
-31% -$18M
XBI icon
6
State Street SPDR S&P Biotech ETF
XBI
$10.1B
$28.6M 1.62%
337,567
+295,901
+710% +$24.8M
TWX
7
DELISTED
Time Warner Inc
TWX
$20.9M 1.18%
228,244
+77,877
+52% +$7.36M
XLRN
8
DELISTED
Acceleron Pharma
XLRN
$15.9M 0.89%
373,481
KANG
9
DELISTED
iKang Healthcare Group, Inc.
KANG
$15M 0.85%
951,464
-549,402
-37% -$7.94M
GS icon
10
Goldman Sachs
GS
$313B
$14.5M 0.82%
56,832
-6,597
-10% -$1.62M
NYT icon
11
New York Times
NYT
$11.6B
$14.2M 0.8%
766,889
-289,014
-27% -$5.37M
ATEX icon
12
Anterix
ATEX
$1.83B
$14M 0.79%
516,274
-198,268
-28% -$6.38M
IBKR icon
13
Interactive Brokers
IBKR
$40.9B
$12.5M 0.71%
845,096
-264,536
-24% -$3.61M
NRE
14
DELISTED
NorthStar Realty Europe Corp.
NRE
$12M 0.68%
891,000
-182,117
-17% -$2.52M
ARGX icon
15
argenx
ARGX
$57.4B
$11.3M 0.64%
179,560
-20,440
-10% -$669K
HD icon
16
Home Depot
HD
$332B
$10.9M 0.61%
57,357
-14,500
-20% -$2.5M
BFH icon
17
Bread Financial
BFH
$4.21B
$10.4M 0.59%
51,562
SBGI icon
18
Sinclair Inc
SBGI
$974M
$10.4M 0.59%
275,097
+86,275
+46% +$2.86M
AGEN
19
Agenus
AGEN
$249M
$9.79M 0.55%
163,104
-13,633
-8% -$1.04M
KMX icon
20
CarMax
KMX
$8.27B
$9.7M 0.55%
151,253
-101,900
-40% -$7.27M
HUNT
21
DELISTED
Hunter Maritime Acquisition Corp. Common Stock
HUNT
$9.66M 0.55%
1,000,000
CMBT
22
CMB.TECH NV
CMBT
$4.57B
$8.71M 0.49%
941,713
-1,272,261
-57% -$10.7M
IOVA icon
23
Iovance Biotherapeutics
IOVA
$2.23B
$8.62M 0.49%
1,124,295
+463,486
+70% +$3.72M
NAT icon
24
Nordic American Tanker
NAT
$1.37B
$8.55M 0.48%
3,703,929
+3,453,929
+1,382% +$14.3M
JPM icon
25
JPMorgan Chase
JPM
$939B
$8.11M 0.46%
75,849
-8,804
-10% -$891K

Similar funds

QVT Financial's Q4 2017 Portfolio in Review

As of Q4 2017, QVT Financial held 75 positions worth $1.77B, down 34% from $2.68B the previous quarter. Its ten largest holdings account for 80% of the portfolio.

QVT Financial withdrew a net $611M in Q4 2017, closing 14 positions and reducing 26 holdings. Its most notable exit was iShares Biotechnology ETF, an estimated $41.5M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 58% of assets, up from 48% a quarter earlier, followed by Consumer Discretionary and Communication Services.

Against the trend, QVT Financial opened a new position in Qorvo worth $6.99M.

  • QVT Financial's largest Q4 2017 buy was Qorvo: 105,000 shares worth $6.99M.
  • QVT Financial added most to State Street SPDR S&P Biotech ETF in Q4 2017, an estimated $24.8M increase.
  • QVT Financial's biggest Q4 2017 reduction was MakeMyTrip, cutting an estimated $18M.
  • QVT Financial fully exited iShares Biotechnology ETF in Q4 2017, selling an estimated $41.5M.
  • QVT Financial's ten largest holdings make up 80% of its $1.77B portfolio in Q4 2017.
  • QVT Financial opened 9 new positions and closed 14 in Q4 2017.
  • QVT Financial's portfolio value fell 34% quarter-over-quarter to $1.77B.

Based on QVT Financial's 13F filing for Q4 2017, filed 14 Feb 2018.